Posts Tagged ‘Biotech’
Debiopharm and Merck invest in artificial intelligence
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital arm of Merck, and Omnes Capital invested CHF 15.5 million in French startup Iktos By 2025, one in two drugs is expected to be discovered and developed using artificial intelligence. Iktos is a French…
Read MoreOculis Announces US public listing on Nasdaq
A Swiss Health Valley success story! Oculis goes public. Oculis Holding AG (“Oculis”), based at EPFL Innovation Park in Lausanne, is a global biopharmaceutical company purposefully driven to save sight and improve eye care. On 3 March 2023, it announced its listing on Nasdaq after successfully closing the business combination between European Biotech Acquisition…
Read MoreFluoSphera Secures a Pre-Seed Investment of $ 1M
The US accelerator IndieBio New York which is part of SOSV, Swiss-based Mountain Labs, and EFI Lake Geneva Ventures participated in this round along with private business angels. Gregory Segala, CEO and co-founder of FluoSphera SA: “We express our deep gratitude to our investors who believe in the potential of our powerful in vitro…
Read MoreLeenaards Foundation 2023 Science Prizes
Leenaards Foundation announces three winners of the 2023 Science Prizes. CHF 1.5 million are awarded to support biomedical research in the Swiss Health Valley The Leenaards Foundation will hand out its annual Science Prize, together with over CHF 1.5 million in award money, to three research groups in the Lake Geneva region at a…
Read More13 biotech companies to watch according to BioAlps and Labiotech.eu
BioAlps recently collaborated with Labiotech.eu to detect the 13 biotech and healthtech companies in the Swiss Health Valley to watch in 2023. Adiposs Headquarters: Geneva Founded: 2020 Adiposs has developed ImageBAT, a first-in-class medical imaging product for brown adipose tissue. Brown fat plays a central role in human metabolism and has a big…
Read MoreXsensio announces an agreement with Mayo Clinic
Xsensio Announces Know-How and Stock Purchase Agreement with Mayo Clinic Xsensio, a Vaud-Based company that is developing the Lab-on-Skin© sensing platform, announced that it has entered into a know-how and stock purchase agreement with Mayo Clinic for the development of new wearable products based on short term health dynamics in critical care. Xsensio will…
Read MoreFONGIT Innovation Fund
Send your application before 13 May 2026 for the FONGIT Innovation Fund (FIF) FONGIT, Fondation Genevoise pour l’Innovation Technologique, is the first innovation incubator in Switzerland, specialising in technological innovation in Geneva. The organisation currently supports more than 100 startups and projects in the fields of ICT, Engineering, and Life Sciences. It helps innovative projects…
Read MoreLonza invested CHF 1 billion in Visp in 2022
The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total of CHF 6.2 billion Lonza has invested one billion francs in Visp (VS) and half a billion in Stein (AG) in 2022, according to the chairman of the group’s board of directors, Albert Baehni. Some…
Read MoreCHUV, Alithea Genomics and PanGene partner to develop a pan-cancer blood test
The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king pan-cancer blood test to guide immune checkpoint inhibitor (ICI) therapy. The consortium combines an expertise in clinical research, transcriptomics and kinomic profiling to take a radically new approach to identify a multi-omics biomarker profile…
Read MoreBioAlps and the Swiss Health Valley
Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role of BioAlps association. Here is the transcription of the interview. ▶️ Listen to the podcast on Labiotech.eu | From 00:31:50 to 47:30 Could you tell us about BioAlps – when it was formed,…
Read More